GlassScriptPhysician profile
Marcus Corkern
NPI 1457764094
$752.06
in general payments reported to CMS, 2019-2025
8 companies · $16.02 in 2025
The $16.02 reported for 2025 was less than what a typical General Practice (Dentist) provider received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $82.30 · 2021: $170 · 2022: $180 · 2023: $166 · 2024: $137 · 2025: $16.02.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $319.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $319.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimvie INC. | $315.19 | 2022-2024 | |
| Align Technology, INC. | $233.90 | 2019-2023 | Itero Element 5d Plus Lite, Itero Element 5d Plus |
| Zimmer Biomet Holdings, INC. | $73.88 | 2019-2021 | |
| 3m Company | $45.75 | 2019-2022 | |
| Straumann USA LLC | $27.00 | 2019 | |
| Voco America INC. | $25.98 | 2021-2024 | Admira Fusion X-Tra, Voco Profluorid Varnish |
| Dentsply Sirona INC | $16.02 | 2025 | Q-Mix |
| Solventum Corporation | $14.34 | 2024 | 3m Espe Filtek Supreme Ultra Universal Restorative, 3m Scotchbond, 3m Relyx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marcus Corkern listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.